Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Two conformational forms of target-bound iC3b that distinctively bind complement receptors 1 and 2 and two specific monoclonal antibodies.

Nilsson UR, Funke L, Nilsson B, Ekdahl KN.

Ups J Med Sci. 2011 Mar;116(1):26-33. doi: 10.3109/03009734.2010.528465. Epub 2010 Nov 11.

2.
3.

Transfer of prostasomal CD59 to CD59-deficient red blood cells results in protection against complement-mediated hemolysis.

Babiker AA, Ronquist G, Nilsson UR, Nilsson B.

Am J Reprod Immunol. 2002 Mar;47(3):183-92.

PMID:
12069204
4.

C3 adsorbed to a polymer surface can form an initiating alternative pathway convertase.

Andersson J, Ekdahl KN, Larsson R, Nilsson UR, Nilsson B.

J Immunol. 2002 Jun 1;168(11):5786-91.

6.

Complement C3b interactions studied with surface plasmon resonance technique.

Jokiranta TS, Westin J, Nilsson UR, Nilsson B, Hellwage J, Löfås S, Gordon DL, Ekdahl KN, Meri S.

Int Immunopharmacol. 2001 Mar;1(3):495-506.

PMID:
11367533
8.

Defective elimination of C3b/iC3b-coated autologous erythrocytes in patients with primary biliary cirrhosis, alcoholic cirrhosis, and ulcerative colitis.

Nilsson Ekdahl K, Lööf L, Ahrenstedt O, Nilsson UR, Nilsson B.

J Lab Clin Med. 1997 Sep;130(3):285-92.

PMID:
9341988
9.
10.

Complement activation during cardiopulmonary bypass: effects of immobilized heparin.

Pekna M, Hagman L, Haldén E, Nilsson UR, Nilsson B, Thelin S.

Ann Thorac Surg. 1994 Aug;58(2):421-4.

PMID:
8067842
11.

Increased in vivo activation of neutrophils and complement in sickle cell disease.

Mohamed AO, Hashim MS, Nilsson UR, Venge P.

Am J Trop Med Hyg. 1993 Dec;49(6):799-803.

PMID:
8279646
12.
13.

Evidence for iC3 generation during cardiopulmonary bypass as the result of blood-gas interaction.

Pekna M, Nilsson L, Nilsson-Ekdahl K, Nilsson UR, Nilsson B.

Clin Exp Immunol. 1993 Mar;91(3):404-9.

14.

Modification of the complement binding properties of polystyrene: effects of end-point heparin attachment.

Nilsson UR, Larm O, Nilsson B, Storm KE, Elwing H, Nilsson Ekdahl K.

Scand J Immunol. 1993 Mar;37(3):349-54.

PMID:
8441922
15.

Complement activation by polymethyl methacrylate minimized by end-point heparin attachment.

Pekna M, Larsson R, Formgren B, Nilsson UR, Nilsson B.

Biomaterials. 1993 Feb;14(3):189-92.

PMID:
8476991
16.

Conformational epitopes of C3 reflecting its mode of binding to an artificial polymer surface.

Nilsson UR, Storm KE, Elwing H, Nilsson B.

Mol Immunol. 1993 Feb;30(3):211-9.

PMID:
7679465
17.
18.

Purification and characterization of porcine C3. Studies of the biologically active protein and its split products.

Storm KE, Arturson G, Nilsson UR.

Vet Immunol Immunopathol. 1992 Oct;34(1-2):47-61.

PMID:
1441229
19.

Lack of evidence for altered complement and immunoglobulin levels in patients with sickle cell anaemia.

Mohamed AO, Nilsson UR, Omar MI, Ronquist G.

Scand J Clin Lab Invest. 1992 Jun;52(4):313-6.

PMID:
1439517
20.

Hereditary dysfunction of the third component of complement associated with a systemic lupus erythematosus-like syndrome and meningococcal meningitis.

Nilsson UR, Nilsson B, Storm KE, Sjölin-Forsberg G, Hällgren R.

Arthritis Rheum. 1992 May;35(5):580-6.

PMID:
1575793
21.

Conformational differences between surface-bound and fluid-phase complement-component-C3 fragments. Epitope mapping by cDNA expression.

Nilsson B, Grossberger D, Nilsson Ekdahl K, Riegert P, Becherer DJ, Nilsson UR, Lambris JD.

Biochem J. 1992 Mar 15;282 ( Pt 3):715-21.

22.

Generation of iC3 at the interface between blood and gas.

Nilsson Ekdahl K, Nilsson B, Pekna M, Nilsson UR.

Scand J Immunol. 1992 Jan;35(1):85-91.

PMID:
1734499
23.

RF-plasma-modified polystyrene surfaces for studying complement activation.

Gölander CG, Lassen B, Nilsson-Ekdahl K, Nilsson UR.

J Biomater Sci Polym Ed. 1992;4(1):25-30.

PMID:
1463697
24.

Defective Fc receptor-mediated clearance in patients with primary biliary cirrhosis.

Ekdahl KN, Lööf L, Nyberg A, Nilsson UR, Nilsson B.

Gastroenterology. 1991 Oct;101(4):1076-82.

PMID:
1889700
25.
26.

An improved method to study complement receptor-mediated function of the fixed macrophage system in vivo.

Nilsson Ekdahl K, Lööf L, Nilsson UR, Nilsson B.

Vox Sang. 1991;61(1):47-52.

PMID:
1949710
27.
29.

Neoantigens in complement component C3 as detected by monoclonal antibodies. Mapping of the recognized epitopes by synthetic peptides.

Nilsson B, Nilsson Ekdahl K, Avila D, Nilsson UR, Lambris JD.

Biochem J. 1990 May 15;268(1):55-61.

30.

In vitro phosphorylation of human complement factor C3 by protein kinase A and protein kinase C. Effects on the classical and alternative pathways.

Forsberg PO, Martin SC, Nilsson B, Ekman P, Nilsson UR, Engström L.

J Biol Chem. 1990 Feb 15;265(5):2941-6.

31.
33.

A simplified assay for the detection of C3a in human plasma employing a monoclonal antibody raised against denatured C3.

Nilsson B, Svensson KE, Inganäs M, Nilsson UR.

J Immunol Methods. 1988 Mar 16;107(2):281-7.

PMID:
3257998
35.
38.

Antigens of complement factor C3 involved in the interactions with factors I and H.

Nilsson B, Nilsson UR.

Scand J Immunol. 1986 Mar;23(3):357-63.

PMID:
2419971
39.
40.
41.
42.

Simplified assays of hemolytic activity of the classical and alternative complement pathways.

Nilsson UR, Nilsson B.

J Immunol Methods. 1984 Aug 3;72(1):49-59.

PMID:
6747305
44.
45.

Altered antigenic expressions of human C3 and C5, their subunits and fragments following exposure to denaturing conditions.

Nilsson UR, Beisswenger JG, Wyman-Caufman S.

Mol Immunol. 1980 Nov;17(11):1319-33. No abstract available.

PMID:
6780785
46.

Effect of reduction on the structural, biologic, and immunologic properties of the third component of human complement.

Zemel ES, Cartwright-Harwick CM, Nilsson UR.

J Immunol. 1980 Sep;125(3):1099-103.

PMID:
7410831
47.

Complement activation in acne vulgaris: consumption of complement by comedones.

Webster GF, Leyden JJ, Nilsson UR.

Infect Immun. 1979 Oct;26(1):183-6.

48.
49.

Further studies of a humoral chemotactic abnormality in glomerulonephritis.

Norman ME, Mandle R, Nilsson UR.

Int Arch Allergy Appl Immunol. 1978;56(2):144-54.

PMID:
621114
50.

Inhibition of complement by mouse serum: selective inactivation of the fourth component of human complement.

Mandle RJ Jr, McConnell-Mapes JA, Nilsson UR.

J Immunol. 1977 Jul;119(1):180-6.

PMID:
874319

Supplemental Content

Loading ...
Support Center